Atrial Fibrillation and Heart Failure.

atrial fibrillation catheter ablation heart failure remodeling

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
29 Apr 2022
Historique:
received: 31 03 2022
revised: 25 04 2022
accepted: 26 04 2022
entrez: 14 5 2022
pubmed: 15 5 2022
medline: 15 5 2022
Statut: epublish

Résumé

Atrial fibrillation (AF) is the most common sustained arrhythmia worldwide and has a strong association with heart failure (HF). It often remains unclear if HF is the cause or consequence of AF due to the complexity of the processes that are involved in both the perpetuation of AF and the development of HF. To date, two therapeutic strategies are accepted as the standard of care in AF patients with heart failure. Rhythm control aims to permanently restore sinus rhythm, whereas a rate-control strategy aims to slow ventricular rate without the termination of AF. In the last 5 years a tremendous number of important studies have been published investigating the optimal therapeutic strategy in HF patients. This review highlights the important studies with respect to the involvement of AF in promoting left-ventricular dysfunction and discusses the optimal strategy in HF patients suffering from AF.

Identifiants

pubmed: 35566639
pii: jcm11092510
doi: 10.3390/jcm11092510
pmc: PMC9103974
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Eur Heart J. 2021 Dec 7;42(46):4731-4739
pubmed: 34453840
JACC Clin Electrophysiol. 2018 Aug;4(8):999-1007
pubmed: 30139501
Circ Res. 2022 Apr;130(7):994-1010
pubmed: 35193397
Pharmacol Res. 2020 Jan;151:104521
pubmed: 31756386
JACC Clin Electrophysiol. 2019 Jun;5(6):681-688
pubmed: 31221354
Eur Heart J. 2020 Mar 7;41(10):1123-1131
pubmed: 31713590
ESC Heart Fail. 2021 Apr;8(2):1666-1674
pubmed: 33314690
Trends Cardiovasc Med. 2015 Aug;25(6):475-84
pubmed: 25661032
Circulation. 2021 Apr 6;143(14):1377-1390
pubmed: 33554614
Eur Heart J. 2021 Feb 1;42(5):373-498
pubmed: 32860505
Eur Heart J. 2020 Aug 7;41(30):2863-2873
pubmed: 31298266
J Interv Card Electrophysiol. 2022 Jan;63(1):207-214
pubmed: 33634337
J Am Coll Cardiol. 2020 Jan 21;75(2):222-232
pubmed: 31948652
N Engl J Med. 2002 Dec 5;347(23):1825-33
pubmed: 12466506
Circulation. 2021 Sep 14;144(11):845-858
pubmed: 34328366
N Engl J Med. 2020 Oct 1;383(14):1305-1316
pubmed: 32865375
J Am Coll Cardiol. 2017 Oct 17;70(16):1949-1961
pubmed: 28855115
Circulation. 2022 Mar 22;:
pubmed: 35313733
Circulation. 2019 Mar 5;139(10):e56-e528
pubmed: 30700139
J Am Coll Cardiol. 2017 Jun 20;69(24):2885-2896
pubmed: 28467883
N Engl J Med. 2008 Jun 19;358(25):2667-77
pubmed: 18565859
JAMA. 2014 Feb 5;311(5):498-506
pubmed: 24496537
Heart Rhythm. 2019 Mar;16(3):424-432
pubmed: 30248459
J Cardiovasc Electrophysiol. 2021 Apr;32(4):916-924
pubmed: 33600025
N Engl J Med. 2018 Feb 01;378(5):417-427
pubmed: 29385358
J Am Coll Cardiol. 2022 Mar 15;79(10):951-961
pubmed: 35272799

Auteurs

Leonard Bergau (L)

Clinic for Electrophysiology, Herz- und Diabeteszentrum Nordrhein-Westfalen, Ruhr Universität Bochum, 32545 Bad Oeynhausen, Germany.
Department of Cardiology and Pneumology, Heart Center, University Medical Center, 37075 Goettingen, Germany.

Philipp Bengel (P)

Department of Cardiology and Pneumology, Heart Center, University Medical Center, 37075 Goettingen, Germany.

Vanessa Sciacca (V)

Clinic for Electrophysiology, Herz- und Diabeteszentrum Nordrhein-Westfalen, Ruhr Universität Bochum, 32545 Bad Oeynhausen, Germany.

Thomas Fink (T)

Clinic for Electrophysiology, Herz- und Diabeteszentrum Nordrhein-Westfalen, Ruhr Universität Bochum, 32545 Bad Oeynhausen, Germany.

Christian Sohns (C)

Clinic for Electrophysiology, Herz- und Diabeteszentrum Nordrhein-Westfalen, Ruhr Universität Bochum, 32545 Bad Oeynhausen, Germany.

Philipp Sommer (P)

Clinic for Electrophysiology, Herz- und Diabeteszentrum Nordrhein-Westfalen, Ruhr Universität Bochum, 32545 Bad Oeynhausen, Germany.

Classifications MeSH